제품 > 재조합 단백질

Recombinant Human IFN-alpha 10 Protein (RP01919)

Bioactivityvalidated

Datasheet

Overview

Product nameRecombinant Human IFN-alpha 10 Protein
Catalog No.RP01919
DescriptionRecombinant Human IFN-alpha 10 Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Cys24-Asp189) of Human IFN-alpha 10/IFNA10 (Accession #NP_002162.1) fused with a Flag at the C-terminus.
Bio-ActivityMeasured in a cell cytotoxicity assay using TF-1 cells. The ED50 for this effect is 0.26‑1.04 ng/mL, corresponding to a specific activity of 9.62×105~3.85×106 units/mg.
Endotoxin<1EU/μg of the protein by LAL method.
FormulationLyophilized from a 0.22 μm filtered solution of PBS, pH 7.4.
SpeciesHuman
Calculated MW20.25 kDa
Interferons (IFN) are a family of cytokines with potent antiviral, antiproliferative and immunomodulatory properties, classified based on their binding specificity to cell surface receptors . Human IFNA2 was originally cloned in the early ‘80s and now more than a dozen closely related IFN alpha subtypes have been identified in both the human and mouse genome, each sharing about 80% amino acid (aa) sequence homology. Structurally, type I IFNs belong to the class of five helicalbundle cytokines, with the IFNA subtypes containing 2 conserved disulfide bonds. Mature human IFNA10 shares 61% aa sequence identity with mouse IFNA7. The type I IFNs bind to the interferon alpha receptor (IFNAR), which consists of two subunits: IFNAR1 (alpha -subunit) and IFNAR2 (beta -subunit). Individual IFNA subtypes are known to display unique efficacies to viral protection, and IFNA10 has been shown to be a strong inducer of IFN-stimulated genes and antiviral protection. Additionally, IFNA10 exhibits weak antiviral effects against SARS-CoV-2 .
SynonymIFNA10; IFN-alpha 10; IFNalpha C; IFN-alpha C; IFN-alpha-10; IFN-alphaC; interferon alpha-10; Interferon alpha-6L; Interferon alpha-C; interferon; alpha 10; LeIF C; MGC119878; MGC119879
Expression HostHEK293 cells
TagC-His
Swiss-Prot
Gene ID
StorageStore at -20℃.Store the lyophilized protein at -20℃ to -80 ℃ up to 1 year from the date of receipt.
After reconstitution, the protein solution is stable at -20℃ for 3 months, at 2-8℃ for up to 1 week.
ReconstitutionCentrifuge the vial before opening. Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. Avoid vortex or vigorously pipetting the protein. For long term storage, it is recommended to add a carrier protein or stablizer (e.g. 0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose), and aliquot the reconstituted protein solution to minimize free-thaw cycles.

* For research use only. Not for therapeutic or diagnostic purposes.

용량을 선택하세요
문의하기